L'Oreal
This article was originally published in The Rose Sheet
Executive Summary
Company developing in vitro UVA sunscreen testing method to validate in vivo Persistent Pigment Darkening assay, the company tells FDA in a recent letter reiterating its preference for the PPD method in measuring UVA protection levels. Having both validated methods "should accurately and quantitatively measure the corresponding protection benefits," L'Oreal says. The company also voices its support for separate UVA and UVB labeling; FDA is considering leaving SPF as the primary indicator of sunscreen protection (1"The Rose Sheet" Feb. 14, p. 6)
You may also be interested in...
L’Oréal Study Supports Proposed SPF/PPD Method For Assessing UVA
UVA protection in sunscreen labeling should be classified into three categories ranging from low to high, based on a ratio of SPF to persistent pigment darkening, according to L'Oréal scientist M. Jean-Louis Refregier
L’Oréal Study Supports Proposed SPF/PPD Method For Assessing UVA
UVA protection in sunscreen labeling should be classified into three categories ranging from low to high, based on a ratio of SPF to persistent pigment darkening, according to L'Oréal scientist M. Jean-Louis Refregier
L'Oreal Critical Wavelength Criticism Based On "Flawed" Analysis - P&G
L'Oreal used a "flawed technical analysis" in assessing the critical wavelength method as a UVA sunscreen testing assay, Procter & Gamble asserts in May 2 comments to FDA.